Growth Metrics

Bionano Genomics (BNGO) Acquisitions (2021 - 2022)

Bionano Genomics recorded quarterly Acquisitions of $32.0 million in Q4 2022, up 4716.43% quarter-over-quarter from -$694000.0 in Q1 2022, and down 34.73% year-over-year from $49.1 million in Q4 2021.

Bionano Genomics' Acquisitions history runs 2 years deep, the most recent figure standing at $32.0 million for Q4 2022.

  • In Q4 2022, Acquisitions fell 34.73% year-over-year to $32.0 million; the TTM figure through Dec 2022 stood at $31.3 million (down 36.14% YoY), while the FY2022 annual figure was $31.3 million, down 36.14% from the prior year.
  • Acquisitions came in at $32.0 million for Q4 2022 at Bionano Genomics, up from -$694000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $49.1 million in Q4 2021 to a low of -$694000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 528.20 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 24.88 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 18.96 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Bionano Genomics 14.92 Mn 539,417.67 3.25 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 32.04 Mn
Mar 31, 2022 -694,000.00
Dec 31, 2021 49.09 Mn